191 related articles for article (PubMed ID: 22308110)
1. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster.
Humphreys KJ; Cobiac L; Le Leu RK; Van der Hoek MB; Michael MZ
Mol Carcinog; 2013 Jun; 52(6):459-74. PubMed ID: 22308110
[TBL] [Abstract][Full Text] [Related]
2. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG
PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma.
Yang H; Lan P; Hou Z; Guan Y; Zhang J; Xu W; Tian Z; Zhang C
Br J Cancer; 2015 Jan; 112(1):112-21. PubMed ID: 25393367
[TBL] [Abstract][Full Text] [Related]
4. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells.
Hu S; Liu L; Chang EB; Wang JY; Raufman JP
Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer.
Chen CQ; Chen CS; Chen JJ; Zhou LP; Xu HL; Jin WW; Wu JB; Gao SM
Mol Cell Biochem; 2013 Nov; 383(1-2):137-48. PubMed ID: 23867991
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs.
Shi Y; Jia Y; Zhao W; Zhou L; Xie X; Tong Z
Int J Mol Med; 2018 Jul; 42(1):435-442. PubMed ID: 29620153
[TBL] [Abstract][Full Text] [Related]
7. Sodium Butyrate Upregulates miR-203 Expression to Exert Anti-Proliferation Effect on Colorectal Cancer Cells.
Han R; Sun Q; Wu J; Zheng P; Zhao G
Cell Physiol Biochem; 2016; 39(5):1919-1929. PubMed ID: 27771718
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C
Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265
[TBL] [Abstract][Full Text] [Related]
9. miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells.
Humphreys KJ; McKinnon RA; Michael MZ
PLoS One; 2014; 9(11):e112288. PubMed ID: 25379703
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.
Cho JH; Dimri M; Dimri GP
J Biol Chem; 2015 Apr; 290(16):10555-67. PubMed ID: 25737447
[TBL] [Abstract][Full Text] [Related]
11. The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines.
Henrici A; Montalbano R; Neureiter D; Krause M; Stiewe T; Slater EP; Quint K; Ocker M; Di Fazio P
Mol Carcinog; 2015 Aug; 54(8):585-97. PubMed ID: 24375802
[TBL] [Abstract][Full Text] [Related]
12. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer.
Su SF; Chang YW; Andreu-Vieyra C; Fang JY; Yang Z; Han B; Lee AS; Liang G
Oncogene; 2013 Sep; 32(39):4694-701. PubMed ID: 23085757
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
14. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells.
Mazzio EA; Soliman KF
Cancer Genomics Proteomics; 2017 Jan; 14(1):17-33. PubMed ID: 28031235
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer.
Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD
World J Gastroenterol; 2016 Jun; 22(24):5532-9. PubMed ID: 27350731
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of
Halaburková A; Jendželovský R; Kovaľ J; Herceg Z; Fedoročko P; Ghantous A
Clin Epigenetics; 2017; 9():62. PubMed ID: 28603560
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells.
Götze S; Coersmeyer M; Müller O; Sievers S
Int J Oncol; 2014 Oct; 45(4):1715-23. PubMed ID: 25050608
[TBL] [Abstract][Full Text] [Related]
19. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures.
Ernst A; Campos B; Meier J; Devens F; Liesenberg F; Wolter M; Reifenberger G; Herold-Mende C; Lichter P; Radlwimmer B
Oncogene; 2010 Jun; 29(23):3411-22. PubMed ID: 20305691
[TBL] [Abstract][Full Text] [Related]
20. Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p.
You BR; Park WH
Mol Carcinog; 2017 Dec; 56(12):2566-2577. PubMed ID: 28667779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]